RenovoRx Inc (RNXT)

[Blueheel1]

I have no agenda here, other than being a long. But I see this stock as one of the best values I have ever seen in the biotech space. The total market cap is $29MM, and the company has enough cash runway to get to a 60% readout on their phase III - and the 30% readout was incredibly strong.

It's not unreasonable for them to get approval and generate significant revenue ($500MM or more) by 2026. That would imply a valuation of $2.5 Billion (biotechs trade at roughly 5X sales in many cases). Of course, a large biotech or pharma will move quickly once they see compelling phase III data (you don't have to look any further than the WSJ to see these deals occur all of the time).

So, the simple math on a valuation of $2.5 Billion is an 86X return from here. Even a massive haircut to that valuation and you'll make 25-50X once this is commercialized.

Please don't listen to the trolls on this board - they are clearly incentivized in some way, or they wouldn't spend all day posting on a chat board.